Capricor Therapeutics
CAPR
CAPR
132 hedge funds and large institutions have $791M invested in Capricor Therapeutics in 2025 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 44 increasing their positions, 38 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
16% more call options, than puts
Call options by funds: $132M | Put options by funds: $114M
16% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 38
15% more funds holding
Funds holding: 115 → 132 (+17)
Holders
132
Holding in Top 10
4
Calls
$132M
Puts
$114M
Top Buyers
| 1 | +$23.3M | |
| 2 | +$22.5M | |
| 3 | +$22.2M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$19.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.7M |
Top Sellers
| 1 | -$3.93M | |
| 2 | -$3.58M | |
| 3 | -$3.32M | |
| 4 |
BDF
Black Diamond Financial
Towson,
Maryland
|
-$2.59M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.55M |
